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Abstract
Background: A key strategy in improving care for people with chronic obstructive pulmonary disease (COPD) is
the provision of pulmonary rehabilitation programmes. Pulmonary rehabilitation programmes have been successful
in improving patients’ sense of dyspnoea and Health Related Quality of Life. However, the effectiveness of
structured education pulmonary rehabilitation programmes delivered at the level of the general practice on the
health status of people with COPD remains uncertain and there is a need for a robust and fair assessment of this.
The PRINCE study will evaluate the effectiveness of a Structured Education Pulmonary Rehabilitation Programme
(SEPRP), delivered at the level of the general practice, on the health status of people with COPD.
Methods/Design: The PRINCE Trial is a two-armed, single blind cluster randomised trial conducted in the primary
care setting in Ireland. Randomisation to control and intervention is at the level of the General Practice. Participants
in the intervention arm will receive a SEPRP and those allocated to the control arm will receive usual care. Delivery
of the SEPRP will be by a practice nurse and physiotherapist in the General Practice (GP) site. The primary outcome
measure of the study will be health status as measured by the Chronic Respiratory Questionnaire (CRQ). Blinded
outcome assessment will be undertaken at baseline and at twelve-fourteen weeks after completion of the
programme. A comparison of outcomes between the intervention and control sites will be made to examine if
differences exist and, if so, to what extent between control and experimental groups. Sample size calculations
estimate that 32 practices with a minimum of 10 participants per practice are required, in total, to be randomised
to control and intervention arms for power of at least 80% with alpha levels of 0.05, to determine a clinically
significant change of 0.5 units in the CRQ. A cost effectiveness analysis will also be conducted.
Discussion: The results of this trial are directly applicable to primary care settings in Ireland. Should a SEPRP delivered
by practice nurses and physiotherapists in primary care be found to be effective in improving patients’ sense of
dyspnoea and HRQoL, then the findings would be applicable to many thousands of individuals in Ireland and beyond.
Trial registration: ISRCTN: ISRCTN52403063
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By 2030, COPD will rank seventh in the worldwide bur-
den of disease [1] and will be the third most frequent
cause of death [2]. Few countries, however, have good
population-based data on COPD and estimates of the
prevalence of COPD differ widely, depending on the cri-
teria that are used. Halbert et al. [3] report prevalence
rates of 0.23% to 18.3% in Europe and North America
with typical rates of 4 to 10%. The Burden of Obstruc-
tive Lung Disease (BOLD) initiative found that the pre-
valence rates of stage II or higher COPD was 10.1%
greater than that reported in previous studies suggesting
that prevalence rates of COPD may be underestimated
[4]. There is little accurate data available on the preva-
lence of COPD in Ireland. A useful comparison may,
however, be made with data from the United Kingdom
where it is estimated that the rate of COPD in the
population attending GPs ranges from 2% - 4%.
COPD is also the leading cause of workdays lost in
the European Union [5]. In Ireland, the Economic and
Social Research Institute [6] found that 20% of inpati-
ent hospital bed days were due to COPD and in those
aged over 65 years, COPD accounted for nearly a third
of respiratory inpatient cases. This implies that if ill-
ness progression can be delayed and acute exacerba-
tions of COPD prevented or reduced then significant
alleviation of the economic and clinical burden could
be achieved [7,8].
One of the key strategies in improving care for people
with COPD is the provision of pulmonary rehabilitation
(PR) programmes. PR programmes utilise a multidisci-
plinary approach and typically consist of a patient
assessment, exercise training, education and psychoso-
cial support [9]. They have been successful in improving
patients’ sense of dyspnoea and Health Related Quality
of Life (HRQoL) [10-12]. PR programmes emphasise
self-care and self-management. However, the extent to
which these programmes meet the criteria for a struc-
tured education programmes [13] is unclear. Structured
education programmes typically consist of a clear philo-
sophy and a written, structured curriculum and include
transparent quality assurance mechanisms. They are
delivered by educators who have been trained to deliver
the programme. Such programmes are more effective in
promoting self-management in chronic conditions than
unstructured education programmes [13].
PR programmes have been predominantly hospital or
home based, although provision in the primary health
care setting has been recommended [14,15]. To date,
only one trial evaluating the effects of pulmonary reha-
bilitation on exercise tolerance and quality of life in peo-
ple with COPD in the primary care setting has been
identified [16]. This study included participants with
asthma (n = 23) and COPD (n = 43). The pulmonary
rehabilitation programme was delivered by a phy-
siotherapist and included exercise classes, breathing
techniques and relaxation activities. Of the 99 partici-
pants randomised, 23 subsequently withdrew and their
outcomes were unavailable for analysis. Of those
remaining, outcome data onq u a l i t yo fl i f e( Q o L )a s
measured by the dyspnoea, fatigue, emotion and mastery
components of the Chronic Respiratory Disease Ques-
tionnaire (CRDQ) are available for only 23 participants.
This study concluded that pulmonary rehabilitation for
patients with COPD or asthma delivered in local prac-
tices improves exercise tolerance and quality of life.
The effectiveness of structured education pulmonary
rehabilitation programmes delivered at the level of the
general practice on the health status of people with
COPD remains uncertain and there is a need for a
robust and fair assessment of this. The PRINCE study
will provide this assessment and will also give people
with COPD an opportunity to voice their experiences of
living with COPD and their approach to self-
management.
Our proposed intervention, a structured education
pulmonary rehabilitation programme, is delivered at the
level of the general practice and is provided to a group
of people with COPD rather than to individual patient
participants. Therefore, the proposed trial is clustered at
the GP practice level.
Aim
The primary aim of the PRINCE study is to evaluate the
effectiveness of a structured education pulmonary reha-
bilitation programme (SEPRP), delivered at the level of
the general practice, on the health status of people with
COPD. The trial has four main objectives:
1. To develop a comprehensive SEPRP specifically
orientated toward delivery by GP practice nurses to
people with COPD in their local communities.
2. To evaluate the effectiveness of the SEPRP within
the context of a cluster randomised trial.
3. To understand participants’ perceptions and
experiences of ‘COPD’, its impact on their lives and
their approach to self-management.
4. To evaluate the cost effectiveness of the provision
of a SEPRP for people with COPD.
Methods
Design
T h eP R I N C ET r i a li sat w o - g r o u p ,s i n g l eb l i n dc l u s t e r
randomised trial conducted in the primary care setting
in Ireland. Randomisation to control and intervention is
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tion of a sufficiently large sample of participants to con-
trol and experimental groups ensures that there are no
systematic differences between control and intervention
groups in known (e.g. motivation) and unknown factors
that may affect the outcome [17]. Participants allocated
to the intervention group will receive a SEPRP and
those allocated to the control group will receive usual
care. Delivery of the PR programme will be by a practice
nurse and physiotherapist in GP sites. Blinded outcome
assessment will be undertaken at baseline and at twelve-
fourteen weeks after completion of the programme.
A comparison of outcomes between intervention and
control sites will be made to examine if differences exist
and, if so, to what extent between control and experi-
mental groups. Randomisation to the PRINCE study
began in September, 2009 and outcome assessment is
due to end in February 2011.
Eligibility Criteria
Participants: GP practices (Clusters)
GP practices across the North Western, Western and
Midland Health Service Executive (Ireland) regions who
meet the following eligibility criteria are eligible to parti-
cipate:
1. Supported by a practice nurse;
2. Practice supported by a computerised patient
(medication recording) system;
3. Commitment on the part of the practice team to
participate in the proposed study;
4. Have a patient population of more than 2500;
5. Participation by a minimum of 10 consenting
patients meeting the eligibility criteria.
Participants: Patients
Primary health care in Ireland is relatively under
resourced and is characterised by poor infrastructure
and limited interdisciplinary teamwork [18]. General
Practitioners tend to operate independently to other pri-
mary health care services leading to a fragmented ser-
vice delivery. Hence, most primary health care settings
in Ireland have not implemented a strategy to proac-
tively diagnose COPD as a part of routine practice. For
this reason, potential patient participants will have
either an existing diagnosis or be suspected of having
COPD. COPD will be suspected when patients are
receiving drug treatment for respiratory conditions,
have a history of tobacco use, a chronic cough, regular
sputum production, frequent winter bronchitis, breath-
lessness or any combination of these. Presence of
COPD will be confirmed at baseline assessment by
spirometry.
D i a g n o s i si sc o n f i r m e dw i t hap o s tB r o n c h i a lD i l a t o r
FEV1/FVC ratio of less than 70%* unless BMI > 30 in
which case FEV1/FVC ratio > 70% are acceptable pro-
vided other criteria are fully met and with a post bron-
chial dilator predicted value of FEV1 ≥ 30% and ≤ 80%
(after Global Initiative for Chronic Obstructive Lung
Disease (GOLD) 2008 [14]). The decision to adjust the
spirometry inclusion criteria for individuals with a BMI
> 30 is based on research undertaken by Wannamethee
et al [19] who demonstrated that BMI was positively
associated with FEV1:FVC.
Patients must be able to converse in and read English
as initial delivery of the SEPRP will only be available in
English. Patients must also understand the study and
give informed consent. Patients will not be excluded if
they have previously attended pulmonary rehabilitation
programmes and all patients will remain under the care
of their GP and/or respiratory physician.
Patients will be excluded from the study if they pos-
sess any significant underlying co-morbidities or mental
health problems (based on the recorded judgement of
practice staff), which are likely to impair their capacity
to successfully participate in or assimilate new informa-
tion as part of the rehabilitation programme or which
may pose a risk to their health. Further detail on patient
eligibility assessment is provided in Table 1.
Interventions
Control Group (usual care)
The control group will receive ‘usual care’.W h i l et h e
research team acknowledge the complexity and potential
heterogeneity of ‘usual care’, substantial effort will be
made to describe clearly the components of ‘usual care’
for COPD patients through information gathered from
structured interviews with GPs, Practice Nurses, docu-
mentary analysis of participants health records and
through interviews with participants. Practice nurses in
the control group will be offered the SEPRP following
the completion of post-programme data collection.
Experimental Intervention
The experimental group will receive the SEPRP, which
focuses on improving the self-management skills of per-
sons with COPD. Structured education programmes are
defined as planned programmes that are: “...comprehensive
in scope, flexible in content, responsive to an individual’s
clinical and psychological needs and adaptable to his or
her educational and cultural background” [13] (pg 27).
Across the literature it is clear that structured educa-
tion should aim to: empower, inform and support self--
management skills. The Department of Health [20]
suggests that the aim of education is to improve knowl-
edge and skills, enabling the person to take control of
their own condition and to integrate self-management
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care service model is most appropriate to chronic dis-
ease management. NICE [13] identify five key criteria
for high quality structured education programmes (i)
programmes should have a structured written curricu-
lum (ii) a patient centred philosophy (iii) be delivered by
trained educators (iv) be quality assured and (v) audited.
The SEPRP was developed in accordance with these key
criteria and in consultation with people with COPD,
experts in pulmonary rehabilitation, general practi-
tioners and practice nurses. The SEPRP was also
informed by a detailed analysis of the literature in rela-
tion to pulmonary rehabilitation programmes.
The programme has been reviewed and validated by
educational experts who were asked to focus on adult
learning and empowerment and experts in pulmonary
rehabilitation and COPD who were asked to focus on
the appropriateness and comprehensiveness of content.
The SEPRP has a course philosophy, a detailed curricu-
lum, course materials and a training programme for all
educators. It is founded on the principles of empower-
ment, self-efficacy and behavioural change theory and
its development was guided by the Stages of Change/
Transtheoretical Model of Behaviour Change [21]. Cen-
tral to the programme is empowering people with
COPD to manage their care well; consequently the pro-
gramme delivery adopts a patient-centred approach with
a focus on priority setting and problem solving. It con-
sists of an eight-week programme with a two-hour ses-
sion each week (16 hours total duration) delivered
jointly by a practice nurse and physiotherapist. An over-
view of programme content is presented in Table 2.
Support following the intervention is thought to be
highly significant in adherence to the programme princi-
ples [22]. For this reason, practice nurses will provide
ongoing advice and support to participants as required
throughout the intervention. In addition, participants in
the intervention will also be followed-up formally at 4
weeks and at 12-14 weeks after completion of the SEPRP.
The 4-week follow up is by telephone and aims to pro-
vide positive reinforcement to those adhering to the pro-
gramme, identify any barriers preventing participants
from adhering to the programme and discuss strategies
to overcome these. At the 12-14 weeks follow up, partici-
pants will be asked to attend a 1-hour group session.
This session will be delivered by the practice nurse. It
builds on the eight-week structured education pro-
gramme and aims to further empower inform and sup-
port persons with COPD to continue self-managing their
COPD. Similar to the eight-week structured education
programme, this follow up programme is underpinned by
the principles of adult learning, an empowerment philo-
sophy and the transtheoretical model of change. The
focus of this programme is to facilitate clients to self eval-
uate their progress, appraise their achievements, problem
solve and plan for the future.
It should be noted that we are not seeking to evaluate
individual components of SEPRP but rather the entire
programme. If there is a beneficial effect in outcomes
for participants in the intervention arm we will be able
to conclude that SEPRP is effective but will not be able
Table 1 Patient exclusion criteria
History of Currently:
￿ Unstable cardiovascular disease
ο unstable angina Suspected or on treatment of
relevant and/or current infectious
disease (e.g. TB)
ο unstable aortic valve disease ￿ In the 3
rd Semester of Pregnancy
ο unstable pulmonary
hypertension
￿ Haemoptysis of unknown origin
￿ Pneumothorax
￿ Thoracic or Cerebral Aneurysms Having had within:
￿ Musculoskeletal or neurological
disorders that prevent gentle
exercise
1 Month:
￿ Severe cognitive impairment ￿ Myocardial infarction
3
￿ Severe psychotic disturbance ￿ Eye Surgery
￿ Detached Retina 3 Months
￿ Relative contraindications include ￿ Abdominal or thoracic surgery
ο a’resting heart rate of more
than 120
3
ο a’systolic blood pressure of
more than 180 mm Hg
ο a’diastolic blood pressure of
more than 100 mm Hg
Table 2 Content of SEPRP
Week Content Educator
Week 1 Setting the scene Practice Nurse
Introduction to exercise Physiotherapist
Week 2 Managing medications Practice Nurse
Exercise programme Physiotherapist
Week 3 Exercise programme Physiotherapist
Exercise programme Physiotherapist
Week 4 Managing breathlessness Practice Nurse
Exercise programme Physiotherapist
Week 5 Knowing and managing your
symptoms
Practice Nurse
Exercise programme Physiotherapist
Week 6 Recognising and managing acute
exacerbations
Practice Nurse
Exercise programme Physiotherapist
Week 7 Exercise programme Physiotherapist
Managing stress and anxiety Practice Nurse
Week 8 Exercise programme Physiotherapist
Where to now? Practice Nurse
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tributed most to such effectiveness.
Practice Nurse Preparation Programme
Practice Nurses will attend a three day Practice Nurse
Preparation Programme (PNPP) to prepare them to deli-
ver the SEPRP.
The programme has four main components: (1) under-
standing the philosophy of the SEPRP, (2) principles of
adult learning and effective management of small groups,
(3) an introduction to programme materials and
approaches to its implementation and (4) assessment of
competence in delivery. Sessions are interactive and geared
towards meeting participants’ learning goals and needs.
This programme was reviewed and validated by outside
experts and was also piloted. The PNPP will be delivered
in two stages. The initial two-days will focus on preparing
practice nurses to deliver the SEPRP and on building con-
fidence (Components 1, 2, 3). On the third day, held a
week later, participants will role play delivering to their
peers an assigned element of the structured education pro-
gramme (Component 4). The research team will observe
these presentations and feedbacks to each participant on
their performance including their adherence to lesson
plans and activities within the SEPRP curriculum. Provid-
ing participants with an opportunity to present a segment
of the SEPRP will increase their confidence and skills for
delivering the SEPRP. To ensure standardisation of pro-
gramme content and delivery, members of the research
team will deliver all PNPP training programmes. Practice
nurses will be audited when delivering the SEPRP pro-
grammes in weeks 4 or 5 to ensure adherence to pro-
gramme principles and content. An action plan will be
developed and followed up as required.
Physiotherapist Preparation Programme
Physiotherapists will attend a one-day Physiotherapist
Preparation Programme (PPP) focused on preparing
physiotherapists to deliver the structured education pro-
gramme. Programme content aims to prepare partici-
pants to: (1) understand the philosophy of the SEPRP,
(2) understand and apply the principles of adult learning
and effective management of small groups, (3) under-
stand programme materials and approaches to its imple-
mentation and (4) deliver the exercise component of the
programme as planned. Sessions will be interactive and
geared towards meeting participants’ learning goals and
needs. There are 10 exercise stations each of 3 minutes
duration focused on building exercise capacity, and tai-
lored to each participant’s individual needs. These exer-
cises will also be repeated at home and recorded by
participants in a home exercise diary.
Again to ensure standardisation of programme content
and delivery, members of the research team will deliver
all PPP programmes. Physiotherapists will also be audited
in their facilitation of the SEPRP programmes in weeks 4
or 5 to ensure adherence to programme principles and
content. Similar to the PNPP, an action plan will be
developed and followed up if required.
All educators (practice nurses and physiotherapists)
will be supported in the delivery of the programme over
t h ee i g h tw e e k sb yh a v i n gr e c o u r s et om e m b e r so ft h e
research team for purposes of clarification on training
materials and in identifying sources of information in
response to specific patient queries.
Outcome measures
Outcome measures will be collected from participants in
both intervention and control groups at baseline (following
consent, prior to randomisation and group allocation) and
at 12-14 weeks post completion of the 8-week programme
or at an equivalent time for the control group. We acknowl-
edge that a longer follow-up period would be desirable but
funding does not permit follow-up beyond this.
Each participating practice will be assigned a Research
Assistant responsible for outcome assessment on all par-
ticipating patients within that practice. To enhance the
quality of measurements, all Research Assistants will
undergo a one-day Research Assistant Preparation Pro-
gramme consisting of:
i) Training on the procedures and protocols sur-
rounding the delivery, assessment and recording of
all outcome measurements;
ii) Discussion on adverse events and their
management;
iii) Simulated completion of all data collection
instruments and forms;
iv) Basic Life Support training (for those requiring
certification);
Primary
The primary outcome measure of the study will be
health status as measured by the Chronic Respiratory
Questionnaire (CRQ) [23]. This instrument was devel-
oped following interviews with people who had COPD
[23]. The questionnaire has four domains: dyspnoea,
fatigue, emotional function and mastery.
The validity and reliability of this tool was first investi-
gated by Wijkstra et al. [24] who concluded that the
CRQ was a valid and reliable tool. This conclusion was
also confirmed by Curtis and Patrick [25] who found that
the CRQ was reliable, valid and responsive to change. In
addition, they claim that the CRQ is more sensitive to
change than other generic health status instruments.
Secondary
1. Incremental Shuttle Walking Test;
2. Self-Efficacy for Managing Chronic Disease 6-Item
Scale [26];
Murphy et al. BMC Pulmonary Medicine 2011, 11:4
http://www.biomedcentral.com/1471-2466/11/4
Page 5 of 103. Economic analysis specific:
a) EuroQol EQ-5D [27];
b) Utilisation of health care Service Utilisation of
health care Service. For variables, i to v, we are
dependent on practice notes for their determina-
tion. Based on our previous experience [28,29]
we consider these to be reliable and valid:
i) Hospital admissions/length of stay;
ii) Attendance at the emergency department;
iii) Outpatient attendances;
iv) Attendance at/by GP;
v) Attendance at/by Practice Nurse;
vi) Attendance at/by Public Health Nurse;
vii) Attendance at/by Physiotherapy;
viii) Attendance at/by Social Worker;
ix) Attendance at/by Dietician;
x) Outpatient attendances;
xi) Attendance at/by consultant;
xii) Utilisation of Home help;
Demographic variables
Data will be collected from each patient participant on
current medication use, smoking history, education level,
marital and employment status, level of social engage-
ment and level of support with activities of daily living.
Sample Size Estimation
We used methods for standard sample size estimates for
trials that randomised at the level of the individual [30]
adjusting for clustering by inflating sample size esti-
mates by the design effect given by 11 +− () n ,w h e r e
n is the average cluster size, and r is the estimated
intraclass correlation coefficient (ICC) [31]. Sample size
estimates are based on the primary outcome of health
status as measured by the CRQ [23], expressed as the
mean rate difference between intervention and control
groups.
Previous work suggests 0.5 as the minimal clinically
important mean difference for all four dimensions of the
CRQ [32] and estimates of standard deviations of 1.145
(given as arithmetic mean of 0.88, 1.06, 1.24 and 1.40
for the Dyspnoea, Fatigue, Emotion and Mastery dimen-
sions of the CRQ respectively) [33]. Using these values
and the upper value of 0.05 from a range of ICC values
identified within studies involving the older person in
primary care, [34] calculations indicate that 32 practices
with a minimum of 10 participants per practice are
required, in total, to be randomised to control and inter-
vention arms for power of at least 80% with alpha levels
of 0.05. This allows for participant loss to follow-up of
20% plus a loss of 4 practices. ICC values lower than
0.05 would increase the power of the study.
Randomisation
Random allocation sequence generation
Randomisation is at the level of the general practice
(cluster). The random allocation sequence will be gener-
ated using a computer generated random number list
[35]. To minimise the time delay between practices
agreeing to participate and the commencement of the
training programme for practice nurses and the imple-
mentation of the intervention for experimental clusters
and patients therein, practices will be randomised in
blocks of clusters when all patient participants in the
block of clusters have been recruited. We propose to
randomise clusters in four groups of clusters on a 1:1
ratio. This approach is recognised as a legitimate means
of overcoming long delays between recruitment and
implementation of the intervention in cluster trials [36].
Allocation concealment
Concealment of group allocation will be achieved by
giving the responsibility for allocation sequence genera-
tion and group allocation to a researcher independent of
the study and its investigators.
Implementation
The research team will provide the independent
researcher with a list of the first group of participating
practices that meet the eligibility criteria and consent to
participate. The independent researcher will then
(i) consecutively number all participating practices in
this group (ii) generate the random allocation sequence
as detailed (iii) assign practice to group allocation and
(iv) notify the PRINCE Project Manager of the practice
allocations. The same allocation procedure will be
followed for subsequent groups.
Blinding
Patient participants within each participating practice will
be recruited prior to random allocation of practices to
control and intervention groups. Because of the nature of
the intervention, it is not possible to blind participants
(GP Practices or clients) to practice group allocation. Out-
come assessment will be blinded to group allocation by (i)
blinding Research Assistants responsible for outcome
assessment to the group allocation of participating prac-
tices and patients with any exceptions recorded and (ii)
having data analysis performed by researchers and statisti-
cians blinded to group allocation by providing database of
outcomes with groups identified numerically only.
Quantitative Analysis
The analysis will be based on the GP Practice with the
patient as the unit of analysis whilst accounting for the
intracluster correlation coefficient. Analyses will be by
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aggregate, using The Statistical Package for the Social
Sciences (SPSS, v17) and R ([37], 2.11). Data will be
entered into SPSS, coded, cleaned and locked before any
analyses are made. Only members of the research team
who needed access to the database to fulfil their roles
within the study were granted access to the database.
Funders did not have access to the database at any time.
Demographic characteristics of the practices and the
participants within the practices will be described using
percentages, measure of central tendency (means or
medians) and measures of variation (standard deviations
or ranges). Comparability of randomised groups by
socioeconomic and other categorical baseline variables
will be by the chi-square (X
2) test.
Whilst every effort will be made to exclude all con-
founders at the design phase of the study, this is not
always possible. The analysis of data will therefore
include the search for and control of nuisance variables
for which adjustments had not been made. In particular,
a mixed effects model will be used to model the longitu-
dinal change in the mean scores for each of the four
dimensions of the CRQ primary response while adjust-
ing for explanatory variables and baseline CRQ as
needed and incorporating random effects to model the
homogeneity within cluster and the correlation within
patient across time. The Akaike information criterion
(AIC), for linear mixed-effects models in the analysis of
clustered data, will be used to decide between candidate
models [38]. The significance level will be set at a =
0.05 for all analyses.
Rigour
Treatment fidelity
Threats to treatment fidelity will be minimised by pro-
viding the SEPRP, PNPP and PPP programmes within
the context of comprehensive, structured curriculum
documents and through delivery of training by members
of the research team. Each programme will be audited
in week 4 or 5 to assess adherence to programme prin-
ciples. An action plan will be implemented if there are
any concerns regarding adherence to programme con-
tent and principles. Providing PNPP participants with
structured feedback (Component 4 above) will also
enhance treatment fidelity.
Data Integrity
Data integrity will be enhanced by having data collection
performed by a small number of trained research assis-
tants and by adherence to assessment protocols.
Errors will be logged and remedial strategies imple-
mented as required. The central study processes (e.g.
eligibility assessment, outcome assessment etc.) will be
kept under review to add to the rigour of the study.
Single data entry into SPSS will be performed with
visual verification of a sample of records from the data
set created from the single entry using a continuous
sampling plan (CSP-1) (after [39]). A CSP-1 gives the
number of successive records with no data entry errors
that must be inspected i before a random sample frac-
tion f of records will begin. Whenever an error is found,
the error is corrected and the successive record check-
ing using i is repeated.
Adverse events
All adverse events that occur after informed consent will
be recorded on an Adverse Event Recording Form
(AERF) and reported to the patients General Practi-
tioner within the respective practice and to the principal
investigators. The PRINCE team have provisionally
defined an adverse event as ‘Any acute alteration in the
patient’s physiological condition’. A protocol for dealing
with adverse episodes has been developed and is
included as part of the training programme for the
research assistance and practice nurses.
All research assistants will be trained in basic life sup-
port and will carry emergency resuscitation equipment
to all patient assessments. Physiotherapists will also
bring resuscitation equipment to each programme
session.
Pilot study
A pilot study will be conducted with one GP practice.
This pilot will be used to identify problems with the
research design/processes; refine data collection and
analysis; assess adequacy of data sources; examine selec-
tion and enrolment processes; and assess the partici-
pants’ perspective on participating. We will not include
data from the pilot period in the main analyses of the
trial.
Embedded Qualitative Study
Introduction and design
To enhance the overall design of the study a qualitative
strand was added. This approach is described as an
“embedded design” [40]. Embedded designs are used
when the inclusion of qualitative data would be helpful in
addressing secondary research questions within the larger
quantitative study [40]. The overall aim of the embedded
qualitative study is twofold: (1) to examine the processo f
the intervention and (2) to define usual care. The specific
aims of this element of the study are to:
￿ understand participants perceptions of COPD and
its impact on their day-to-day lives;
￿ determine the components of usual care for parti-
cipants allocated to the control group;
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ences of managing COPD prior to the SEPRP;
￿ understand the impact that the SEPRP may have
on participants’ self-management skills;
￿ gain insights into the factors that govern adherence
to programme principles.
Grounded Theory
A grounded theory methodology (after Corbin and
Strauss [41]), was chosen to guide the qualitative ele-
ment of this study because of its focus on how people
respond to and act towards the problems they encoun-
ter [41,42]. Grounded theory aims to produce a theory
to “fit” (i.e. has relevance) the situation, aid understand-
ing and guide action and practice [41]. These are impor-
tant considerations when studying health related
problems. Grounded theory ‘discovers’ theory through
systematic data collection and analysis [41].
Data collection Methods
In-depth, one-to-one interviews (guided by an interview
guide) will be the primary method of data collection. Par-
ticipants will be interviewed on three occasions (1) prior
to the participating in the SEPRP programme (2) within
2-6 weeks of completing the SEPRP and (3) three months
after completion of the programme. This longitudinal
design will enable understanding of the reasons for parti-
cipant’s changes (or not maintaining change) in self-
management skills and their exercise regimes over time.
In addition, observational data (guided by an observa-
tion schedule) will be collected from one session of the
SEPRP for each group from which the sample is drawn.
This data will help set the interviews in context. In addi-
tion to providing contextual data, the literature suggests
that the group experience (the synergistic effect of the
group) may be an important factor in behaviour mainte-
nance. Observational sessions will be of two hours dura-
tion i.e. observing a one-hour SEPRP delivered by the
practice nurse (detailed in Table 2) and one-hour deliv-
ered by the physiotherapist where participants complete
an exercise circuit.
Sampling in the intervention group
Twenty participants will be recruited from those allo-
cated to the intervention group using purposive sam-
pling initially and theoretical sampling later on (guided
by data analysis) to ensure diversity of experiences. The-
oretical sampling is the process of simultaneously col-
lecting, coding and analysing data to generate theory
[41]. Grounded theorists do not seek representativeness
of people or events but the representativeness of “con-
cepts” [41]. Sampling decisions are driven by “... concepts
that emerged from analysis and that appear to have
relevance to the evolving theory” [43]. To ensure
participant diversity in the initial purposive sample, the
following inclusion criteria will be used:
￿ Severity of COPD - people with moderate to severe
COPD (as defined by the study protocol) will be
included;
￿ GP practice size - people attending GP Practices
with (1) between 2,500 and 5,000 patients and
(2) over 5,000 patients will be included;
￿ Gender - both men and women will be included;
￿ Location of practice - urban and rural practice set-
tings will be included.
Purposive sampling will be superseded by theoretical
sampling as the study progresses. Theoretical sampling
m a yi n d i c a t et h en e e dt oi n c l u d em o r ed i v e r s ep a r t i c i -
pants and will evolve as the study progresses.
Sampling in the control group
Structured qualitative interviews will be conducted with
ten patient participants and ten practice staff (either
practice nurses or GPs) from the control group. These
participants will be interviewed on one occasion only.
This data will be used to define and describe usual care.
Sampling of staff delivering the SERPS
All practice nurses and physiotherapists who delivered the
SEPRP will be interviewed. This interview will focus on
their experience of delivering the SEPRP. This data will
provide contextual information and insight into how staff
delivered and their experience of delivering the SERPS.
Analysis
The constant comparative technique [41] will be used to
analyse data. Data from each group will be analysed
individually (within group) and, in the case of partici-
pants who completed the SEPRPS i.e. completed three
interviews (across group), to explore the impact of time
on the impact of the SEPRPS. Data will be analysed in
stages (e.g. all the interviews from a practice) reflective
of recruitment phases. This approach enables data ana-
lysis to guide data collection and sampling decisions
(theoretical sampling).
Economic Evaluation
The economic evaluation explores the cost effectiveness
of the PRINCE intervention relative to usual care for
patients with COPD in Ireland. This involves the identifi-
cation, measurement and valuation of all relevant costs
and benefits. The time horizon is equivalent to that of
the follow up for the cluster randomised controlled trial.
Retrospective data on resource use is collected at baseline
and 22 weeks later at the end of the study. Although the
time period is relatively short, the hypothesis is that there
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tion group, most likely a reduction in the probability of
being hospitalised, which will yield significant levels of
savings [44]. Incremental cost effectiveness analysis is
used, whereby we estimate the differences in mean cost
and mean effectiveness across treatment arms, and relate
the difference in mean cost to the difference in mean
effectiveness. Uncertainty surrounding the incremental
results is assessed using cost effectiveness acceptability
curves, which will present the weight of evidence in
favour of intervention relative to control.
With respect to costs, we consider both the healthcare
resource requirements and the private patient expenses
associated with each treatment group.
Specifically, we collect data on three areas of
resource use alongside the trial: Intervention costs,
which include all the resources required to organise
and implement the Structured Pulmonary Rehabilita-
tion Programme in clinical practice, Other healthcare
services costs, which includes the use of all primary
and secondary care over the course of the trial, includ-
ing both community-based care and hospital care,
patient out-of-pocket expenses, which includes the
individual’s own time input in the treatment process
and associated travel expenses.
In terms of effectiveness, our outcome measure of
choice is the Quality Adjusted Life Years (QALYs). The
QALY is a composite measure of health gain which
simultaneously incorporates the impact of treatment in
terms of health related quality of life and life expec-
tancy. Health related quality of life data, as measured by
the Euroqol (EQ5D) questionnaire, is collected alongside
the clinical trial and baseline and follow up values will
be combined to estimate QALY gains for each indivi-
dual, and for each treatment arm.
Ethical Considerations
Ethical approval has been granted by the Research Ethics
Committee of the National University of Ireland, Galway
and the Irish College of General Practitioners (ICGP).
Discussion
The results of this trial will be directly applicable to pri-
mary care settings in Ireland. Should a structured edu-
cation pulmonary rehabilitation programme delivered at
the level of the GP practice be found to be effective in
improving patients’ sense of dyspnoea and HRQoL then
the findings would be applicable to many thousands of
individuals in Ireland and beyond.
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